Immediate Impact
1 by Nobel laureates 7 from Science/Nature 66 standout
Citing Papers
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Multiple sclerosis
2023 Standout
Works of Aaron E. Miller being referenced
Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis
2016
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Aaron E. Miller | 376 | 143 | 130 | 147 | 17 | 644 | |
| Theodora A. M. Siepman | 392 | 161 | 73 | 196 | 18 | 631 | |
| Agata Walczak | 342 | 116 | 133 | 199 | 17 | 691 | |
| Francesca De Robertis | 403 | 140 | 114 | 83 | 18 | 605 | |
| Jeffrey I. Greenstein | 209 | 111 | 126 | 134 | 28 | 543 | |
| Ester Cantó | 317 | 139 | 193 | 133 | 15 | 573 | |
| Barbara Teter | 394 | 92 | 103 | 72 | 25 | 626 | |
| Rana Zabad | 329 | 164 | 133 | 90 | 34 | 705 | |
| Y.K Semra | 254 | 120 | 253 | 213 | 19 | 598 | |
| G. Grimsley | 365 | 237 | 86 | 116 | 14 | 577 | |
| T. Arbizu | 550 | 211 | 114 | 153 | 28 | 728 |
All Works
Loading papers...